Diabetes, Vol 45, Issue 6 749-754, Copyright © 1996 by American Diabetes Association

ARTICLES

Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats: expression of Th1 cytokines correlates with beta-cell destructive insulitis and IDDM

A Rabinovitch, W Suarez-Pinzon, A El-Sheikh, O Sorensen and RF Power
Department of Medicine, University of Alberta, Edmonton, Canada.

Cytokines produced by islet-infiltrating mononuclear leukocytes may be involved in islet beta-cell destruction and IDDM. To determine which cytokine(s) might be involved in islet beta-cell destruction, we used a reverse transcriptase-polymerase chain reaction assay to compare levels of cytokine mRNA expression in mononuclear leukocytes freshly isolated from islets of four groups of BB rats aged 60-75 days: diabetes-prone (DP) rats, DP rats protected from diabetes by injection of complete Freund's adjuvant (CFA) at age 25 days, acutely diabetic rats, and diabetes-resistant (DR) rats. We found that islet mononuclear leukocyte levels of gamma-interferon (IFN-gamma) mRNA were significantly higher in DP and diabetic rats than in DR rats, whereas CFA-treated DP rats had similar IFN-gamma mRNA levels to DR rats. Also, interleukin (IL)-2 mRNA levels tended to be higher in islet leukocytes from DP and diabetic rats than from DR rats. Tumor necrosis factor-alpha, IL-4, and IL-10 mRNA levels were not significantly different in islet leukocytes from the four groups of rats. These findings suggest that production of T-helper 1 (Th1)-type cytokines, IFN-gamma and IL-2, by islet-infiltrating cells in BB rats is associated with beta-cell destruction and IDDM development.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Cnop, N. Welsh, J.-C. Jonas, A. Jorns, S. Lenzen, and D. L. Eizirik Mechanisms of Pancreatic {beta}-Cell Death in Type 1 and Type 2 Diabetes: Many Differences, Few Similarities Diabetes, December 1, 2005; 54(suppl_2): S97 - S107. [Abstract] [Full Text] [PDF]

				A. Jorns, A. Gunther, H.-J. Hedrich, D. Wedekind, M. Tiedge, and S. Lenzen Immune Cell Infiltration, Cytokine Expression, and {beta}-Cell Apoptosis During the Development of Type 1 Diabetes in the Spontaneously Diabetic LEW.1AR1/Ztm-iddm Rat Diabetes, July 1, 2005; 54(7): 2041 - 2052. [Abstract] [Full Text] [PDF]

				T. Tabatabaie, A. Vasquez-Weldon, D. R. Moore, and Y. Kotake Free Radicals and the Pathogenesis of Type 1 Diabetes: {beta}-Cell Cytokine-Mediated Free Radical Generation Via Cyclooxygenase-2 Diabetes, August 1, 2003; 52(8): 1994 - 1999. [Abstract] [Full Text] [PDF]

				M. Peppa, C. He, M. Hattori, R. McEvoy, F. Zheng, and H. Vlassara Fetal or Neonatal Low-Glycotoxin Environment Prevents Autoimmune Diabetes in NOD Mice Diabetes, June 1, 2003; 52(6): 1441 - 1448. [Abstract] [Full Text] [PDF]

				M. Chen, Z. Yang, R. Wu, and J. L. Nadler Lisofylline, a Novel Antiinflammatory Agent, Protects Pancreatic {beta}-Cells from Proinflammatory Cytokine Damage by Promoting Mitochondrial Metabolism Endocrinology, June 1, 2002; 143(6): 2341 - 2348. [Abstract] [Full Text] [PDF]

				G. Papaccio, F. Nicoletti, F. Aurelio Pisanti, K. Bendtzen, and M. galdieri Prevention of Spontaneous Autoimmune Diabetes in NOD Mice by Transferring in Vitro Antigen-Pulsed Syngeneic Dendritic Cells Endocrinology, April 1, 2000; 141(4): 1500 - 1505. [Abstract] [Full Text] [PDF]

				W. S. Gallichan, B. Balasa, J. D. Davies, and N. Sarvetnick Pancreatic IL-4 Expression Results in Islet-Reactive Th2 Cells That Inhibit Diabetogenic Lymphocytes in the Nonobese Diabetic Mouse J. Immunol., August 1, 1999; 163(3): 1696 - 1703. [Abstract] [Full Text] [PDF]

				M. E. Baldeon, T. Chun, and H. R. Gaskins Interferon-alpha and interferon-gamma differentially affect pancreatic beta -cell phenotype and function Am J Physiol Cell Physiol, July 1, 1998; 275(1): C25 - C32. [Abstract] [Full Text] [PDF]

				L. E. Olsson, M. A. Wheeler, W. C. Sessa, and R. M. Weiss Bladder Instillation and Intraperitoneal Injection of Escherichia coli Lipopolysaccharide Up-regulate Cytokines and iNOS in Rat Urinary Bladder J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1203 - 1208. [Abstract] [Full Text]

				C. H. Sorli, H.-J. Zhang, M. B. Armstrong, R. V. Rajotte, J. Maclouf, and R. P. Robertson Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet PNAS, February 17, 1998; 95(4): 1788 - 1793. [Abstract] [Full Text] [PDF]

				R. H. Slover and G. S. Eisenbarth Prevention of Type I Diabetes and Recurrent {beta}-Cell Destruction of Transplanted Islets Endocr. Rev., April 1, 1997; 18(2): 241 - 258. [Abstract] [Full Text]

				F. Nicoletti, P. Zaccone, R. Di Marco, M. Lunetta, G. Magro, S. Grasso, P. Meroni, and G. Garotta Prevention of Spontaneous Autoimmune Diabetes in Diabetes-Prone BB Rats by Prophylactic Treatment with Antirat Interferon-{gamma} Antibody Endocrinology, January 1, 1997; 138(1): 281 - 288. [Abstract] [Full Text] [PDF]